Annual Showcase 2026

We are delighted to invite you to our first Annual Showcase of the MRC Medicines Development Fellowship Scheme, an event that will highlight the work of our Clinical Research Training Fellows and Clinician Scientists as well as bringing together leading voices from academia, industry, and regulatory bodies.

Join us for a day of insightful talks and cross-sector perspectives exploring the future of medicines development, clinical trials and the next generation of research leaders. This year's event will take place on 18th June 2026 in London at The Platform, 60 London Wall, EC2M 5TQ.

The event is free to attend but you must register as places are limited.

Download the Annual Showcase 2026 Programme.

Programme

09:30 - 10:00	Arrival/Registration
10:00 – 10:15	Welcome talk Professor Sir Munir Pirmohamed
10:15 – 10:45	Alastair Webb (Clinical Associate Professor in Stroke Medicine, Imperial College London) From stroke epidemiology to cerebrovascular physiology: translating mechanistic human studies into clinical trials
10:45 – 11:00	Dr Emma Magavern (Clinician Scientist, Queen Mary University of London) Characterising the added value of multi-omic biomarkers for medication response in early phase clinical trial drug development in diverse populations
11:00 – 11:10	Dr Simon Gray (Clinical Research Training Fellow, University of Liverpool) Towards an in vivo assessment of immune competence in cancer patients by skin contact sensitisation
11:10 – 11:25	Break
11:25 - 11:35	Dr Louise Aubiniere-Robb (Clinical Research Training Fellow, University of Glasgow) Can AI Close the Gap Between CKD Guidelines and Real-World Care?
11:35 - 12:05	Dr Slavé Petrovski (Vice President for the Centre for Genomics Research at Astra Zeneca) The power of population omics in drug discovery
12:05 – 12:20	Dr Rishi Mukherjee (Clinician Scientist, Univerity of Liverpool) AI/ML Driven Multi-Omic Drug Discovery for Pancreatitis Induced Lung Injury
12:20 – 13:20	Lunch
13:20 – 13:50	Dr Kim Branson (Senior Vice President and Global Head of Artificial Intelligence and Machine Learning, GSK) The Using and developing of AI at GSK
13:50 - 14:00	Dr Jack Thompson (Clinical Research Training Fellow, Queen Mary University of London) What can metabolomics do for early phase clinical trials?
14:00 – 14:30	Dr Carl Anderson (Head of Human Genetics, Wellcome Sanger Institute) From Genetic Maps to Predictive Models: Longitudinal Multiomics for Disease Prediction
14:30 – 14:45	Break
14:45 – 15:15	Professor Jonathan Benger (Chief Executive of NICE) NICE and the future of HTA
15:15 – 15:25	Dr Will Marshall (Clinical Research Training Fellow, University of Manchester) The Salford-Kidney-Cardiovascular-Kidney-Liver-Metabolic (SKCKLM) Study
15:25 – 15:55	Professor Rosalind Smyth (Vice Dean (Research), Professor of Child Health University College London) Positive developments in clinical academic careers
15:50 – 16:00	Closing Remarks Professor Sir Munir Pirmohamed